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Background
Hypertension is a common chronic disease in Hong Kong, affecting around
10% of the population.1 High blood pressure (BP) is a major risk factor for
stroke and coronary heart disease but the risk can be reduced by treatment.2
There are many international and national guidelines that outline criteria
for selection of patients for treatment and the content and frequency of
monitoring for complications. Nonetheless, studies in other countries have
shown variation in the management of hypertensive patients.3 Such varia-
tion implies that some patients, at least, are not receiving an optimal stand-
ard of care. In order to determine strategies to overcome variations in
care, we need information on current practices and levels of practitioner
awareness.
As a first step in gaining some understanding of the current situation and the
potential for improving care, we have surveyed family physicians about their
management of hypertensive patients.
Aims and objectives
The aim was to identify current practice and any deficiencies in the management
of hypertensive patients in Hong Kong. The specific objectives were:
1. To survey family physicians on their management of hypertensive patients.
2. To compare stated practice patterns with guidelines current at the time for
the management of hypertension.
3. To explore what factors are associated with practices closer to international
guidelines.
Methods
The sample was taken from the Hong Kong College of Family Physicians. At
the start of the survey, in June 1999, there were 1002 members. Questionnaires
were sent with an invitation letter to a random sample of 334 members. Follow-
up surveys were conducted in July and October. Due to the low response rate,
188 questionnaires were distributed at the December 1999 Refresher Programme
organised by the Hong Kong College of Family Physicians.
The questionnaire was based on one previously used to investigate
management practices for hypertensive patients.4 It presents profiles of typical
hypertensive patients and asks questions on diagnosis and management.
Chi squared tests were used to compare proportions. Multivariate logistic
regression was used to determine which of the doctors’ characteristics
(qualifications, experience, use of a hypertension register, use of guidelines,
frequency of seeing hypertensive patients and sector-public or private) independ-
ently contributed to practices adhering to international guidelines, considered
one by one or as overall scores. The World Health Organization5 (WHO)– and
the British Hypertension Society6 (BHS)–published guidelines were used. Tests
were two-tailed at the 5% level of significance. When reporting data in two
categories any missing answers were assumed to be the lower response or a ‘no’
Key Messages
1. Reported practice by the major-
ity of respondents corresponded
to international guidelines for
diagnostic practice, intervention
levels, first-line drugs and life-
style modification for smokers.
2. Reported practice by the major-
ity of respondents did not
correspond to the guidelines
for goal blood pressure levels or
the management of diabetics.
There was uncertainty about
treatment of the elderly.
3. Authoritative local guidelines
on the management of hyper-
tension (with specific advice on
the management of the elderly
and diabetic patients) are
recommended.
4. A follow-up study examining
blood pressure levels in patients
treated for hypertension is
recommended.
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answer so all responses were included; for more than two
categories or averages the missing data were not included
and number of responses is shown.
Results
In response to the initial mailing, 58 questionnaires were
returned, 27 were returned after the first reminder and 19
after the second. From the Refresher Programme a further
18 responses were obtained. All 122 questionnaires were
used for analysis.
Table 1 shows characteristics of the survey respondents.
Between 17% and 26% of the College members have a
fellowship compared with 32% of respondents.
Reported hypertension management
Table 2 shows reported hypertension management practices
compared with the WHO and BHS guidelines that were
current at the time of the survey. In addition, most
respondents said they would screen for the presence of a
positive family history (79%) or risk factors (84%).
The mean minimum observation period before starting
drug treatment for a mild hypertensive with no other risk
factors was 4.8 weeks, compared with the WHO guideline
period of 3 to 6 months. The respondents’ observation
period is closer to the BHS guideline of 4 to 14 weeks for
a patient with BP in the range of 160-199/100-109 mm Hg.
The mean number of measurements before starting drug
treatment is three, the BHS guidelines suggest four. The
WHO guidelines are less specific but three measurements
fit their criteria.
Systolic BP drug treatment thresholds clustered around
160 mm Hg, 150 mm Hg and 140 mm Hg, with the largest
proportion (37%) choosing 160 mm Hg. The diastolic BP
treatment thresholds clustered around 90 mm Hg, 95 mm Hg
and 100 mm Hg, with 40% choosing 90 mm Hg. The WHO
and the BHS guidelines recommend lower treatment
thresholds for diabetics and 32% of respondents reported
lower drug treatment thresholds for diabetics. Most
respondents (62%) had an upper age-limit of 80 years for
starting drug treatment; the BHS guidelines suggest
treating in accordance with biological rather than
chronological age.
The BHS guidelines recommend a thiazide diuretic as
the first-line treatment of choice; less than half of the
respondents (43%) gave a diuretic as their first-line drug.
The WHO and the BHS guidelines recommend a treat-
ment goal under 140/90 mm Hg. Around a quarter of the
respondents (26%) had a goal systolic BP under 140 mm Hg
and less than half (47%) a goal diastolic BP under 90 mm Hg.
Both guidelines recommend a lower treatment goal for
diabetics but fewer than half (40%) would decrease the
goal for diabetics. Lifestyle modification is recommended
as an important part of hypertension management in both
guidelines; 30% of respondents provided educational
programmes for their hypertensive patients. Both guidelines
suggest 3-monthly review is sufficient; most respondents
reported reviewing more frequently.
Factors affecting hypertension management
Screening—respondents with more experience and those
working in the private sector were more likely to report
screening for hypertension, but these associations were
not significant in the multivariate model.
Diagnosis—respondents with more experience, more
qualifications or working in the private sector were more
likely to take three or more BP measurements before
starting treatment. In the multivariate model qualifications
and experience contributed to taking at least three
measurements. Those with a hypertension register were more
likely to observe over 12-24 weeks, but this association was
not significant in the multivariate model.
Drug intervention—respondents with higher qualifica-
tions or more experience were more likely to intervene at or
below the WHO recommended systolic BP levels. The
multivariate model showed no significant associations.
Risk factors—doctors working in the public sector were
more likely to set lower intervention levels for diabetics,
but this association disappeared in the multivariate model.
Respondents in the public sector with guidelines were
more likely to treat those over 80 years than those in the
private sector, with or without guidelines, and those in the
public sector without guidelines.
Drug therapy—respondents in the public sector were
more likely to use a diuretic as a first-line drug; this
association remained significant in the multivariate model.
Goal BPs—respondents with higher qualifications or
not using a hypertension register were more likely to have
a goal systolic BP under 140 mm Hg, but these relation-
ships were not significant in the multivariate model.
Higher qualifications were associated, in the multivariate
model, with having a goal diastolic BP under 90 mm Hg.
Those with less experience or working in the public sector
were more likely to decrease the goals for diabetics but
these associations were not significant in the multivariate
model.
Ongoing management—almost all respondents said
that they asked about smoking and advised quitting.
Table 1.  Characteristics of survey respondents
No. (%)
Work in the private sector 176 (62.3)
Have higher qualifications 172 (59.0)
More than 5 years of experience 189 (73.0)
Have a hypertension disease register 139 (31.9)
Use guidelines for goal blood pressure 156 (45.9)
Would welcome guidelines for drug therapy 111 (91.0)
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Respondents working to guidelines or working in the
public sector were more likely to have educational pro-
grammes and these associations were significant in the
multivariate model.
Working in private practice and not having higher
qualifications independently contributed to more frequent
review. No associations were found between doctor
characteristics and referral to a public sector specialist
but the multivariate model showed that respondents in the
private sector were more likely to refer to Government
Outpatient Clinics.
Overall scores—to summarise the findings, scores
were allocated to each respondent according to the
correspondence between stated practice and published
Table 2.  Summary of reported practices and international guidelines
Reported practices BHS 1999 guidelines WHO 1999 guidelines
Diagnostic procedure
Period of observation prior to drug treatment (n=119)
Mean 4.8 weeks BP 160-199/100-109 mm Hg: 3-6 months
Mode 2 weeks 4-12 weeks; BP 140-159/90-
Median 4 weeks 99 mm Hg: 12 weeks
Minimum BP measurements prior to drug treatment (n=111)
Mean 3.4 4 Multiple measurements on several
Mode 3 separate occasions
Median 3
Intervention levels
Minimum level of established systolic BP to start drug
treatment (n=121)
Mean 155.48 Systolic BP≥160 mm Hg BP≥150/95 for men under 55 and
Mode 160 women under 65 years
Median 160
% at 140 18.2% BP≥140/90 for men of 55 years or
% at 150 21.5% over and women of 65 years or over
% at 160 37.2%
Minimum level of established diastolic BP to start drug
treatment (n=121)
Mean 93.72 Diastolic BP≥100 mm Hg
Mode 90
Median 95
% at 90 39.7%
% at 95 30.6%
% at 100 22.3%
Lower level to start drug treatment for diabetics (n=122)
% Yes 32.0% BP≥140/90 mm Hg BP≥130/85 mm Hg
Start drug treatment in patients over 80 years (n=122)
% Yes 38.5% Treat according to biological age No age limits; uncertainty about
value of treatment for over 80 years
Drug therapy
1st line anti-hypertensive drugs usually prescribed (n=111)
Diuretics 43% Thiazide diuretic All classes for patients under 60
Beta-blockers 28% years; consider cost, patient
CCA/CCB 13% preferences and other conditions
ACE1 14%
Other 2%
Ongoing management
Treatment goal BP—systolic BP (n=120)
Mean 142.86 Systolic BP<140 mm Hg Systolic BP<140 mm Hg for elderly
Mode 140 Systolic BP<130 mm Hg for
Median 140 younger
% <130 1.7%
% <140 25.6%
Treatment goal BP—diastolic BP (n=120)
Mean 88.19 Diastolic BP<85 mm Hg Diastolic BP<90 mm Hg for elderly
Mode 90 Diastolic BP<85 mm Hg for younger
Median 90
% at <85 15.8%
% at <90 46.7%
% at <95 98.3%
Decrease goal for diabetics (n=122)
% Yes 40.2% Diastolic BP<80 mm Hg, Diastolic BP<85 mm Hg, systolic
systolic BP<140 mm Hg BP<130 mm Hg
Educational programmes (n=122)
% Yes 29.5% Non-pharmacological advice 3-12 month trial of lifestyle advice
should be offered to all initially
hypertensive people
Measurement frequency (n=119)
Mean 8.2 weeks 3 monthly should suffice See every 3 months
Mode 4 weeks
Median 8 weeks
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guidelines and the associations between doctors’ character-
istics and scores were explored. Two scores were created.
The WHO score consists of the following items: at least
three measurements in the observation period, observe the
patient over at least 12 weeks, start drug treatment at or
above 140 mm Hg systolic, start drug treatment at or above
90 mm Hg diastolic, intervene at lower levels for diabetics,
have a goal systolic BP under 140 mm Hg, have a goal
diastolic BP under 90 mm Hg, review a stable patient less
often than monthly and have an educational programme. A
point was allocated for each criterion met. Possible WHO
scores range from 0 to 9 with 4 or more considered closer
to the guidelines. The BHS score consists of the following:
at least three measurements in the observation period,
observe for at least 1 month, start drug treatment at or
above 160 mm Hg systolic, start drug treatment at or
above 100 mm Hg diastolic, start lower for diabetics,
use diuretic as first-line treatment, treat those over 80
years old, have a goal systolic BP under 140 mm Hg, have a
goal diastolic BP under 85 mm Hg, have a lower goal for
diabetics, review a stable patient less often than monthly
and have an educational programme. Possible BHS scores
range from 0 to 12 with 5 or more being counted as closer
to the guidelines.
Respondents with higher qualifications were more likely
to score highly against the WHO guidelines and those in
the public sector were more likely to score highly against
the BHS guidelines. In the multivariate model, higher quali-
fications and working in the public sector independently
contributed to practising closer to both guidelines.
Discussion
This study is limited by the low response rate (31%) and
the nature of voluntary audit of reported practice. It is
possible that the respondents are not typical of family
physicians in Hong Kong. Not all the physicians providing
primary care in Hong Kong are members of the College
and the respondents appeared to be slightly more qualified
than the College members, both of these factors would
suggest that the respondents might be better informed and
motivated than the non-respondents. Previous studies have
found that there is not always a strong relationship between
what a doctor reports in a hypothetical case and what
happens in practice. Most people are motivated to show
themselves in a good light. The implications are that the
practice reported here may be overly optimistic and actual
practice is likely to be, on average, poorer. However, the
relationships identified in the analyses are less likely to be
affected by this limitation. In the multivariate analysis,
adjusting for sample member status (ie random or volunteer)
had no effect on the results, nor did adjusting for when the
questionnaire was returned. This supports a conclusion that
the relationships between characteristics and practice were
unaffected by the main limitation.
Respondents had good knowledge of some aspects of
optimal hypertension management guidelines, but there are
gaps and corresponding implications for actual practice.
Most respondents reported practice that fell within the WHO
or BHS guidelines for diagnostic practices, intervention
levels, first-line drugs and lifestyle modification for smokers.
Reported practice was less likely to correspond to either
set of guidelines in frequency of review and treatment
goals. There was particular lack of conformity to guidelines
in treatment of diabetics and the elderly.
Higher qualifications were associated with reported
practices closer to the guidelines, thus demonstrating the
importance of continuing education and the role of the
College of Family Medicine. Working in private practice
was associated with less adherence to the guidelines. We
speculate that the organisation of care is the key factor to
guideline adherence. The majority of respondents did
not use management guidelines. Almost all reported that
they would welcome guidelines for drug therapy. Hence
authoritative guidelines, perhaps from the College, which
focus on the continuing management of hypertension, with
additional advice on the elderly, diabetic patients and
lifestyle modification would be one way forward.
Given the potential shortcomings identified in this
survey it is imperative that this study is followed up by an
audit of actual practice. This could be carried out by
auditing the treatment of a group of hypertensive patients
or by examining how well BP levels in treated hyper-
tensives meet goal BPs in a random sample of Hong Kong
residents.
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